StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Allergan (AGN) Says DARPin to Be Delayed, Shares Sag; Regeneron (REGN) Ramps Higher
May 1, 2013 11:26 AM
Allergan Inc. (NYSE: AGN) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) traded in opposite directions mid-day ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
FDA
Hot FDA News
Trader Talk
Trading Halts
Next Articles
JMP Securities Upgrades Regeneron Pharma (REGN) to Market Outperform
May 2, 2013 7:23 AM
Lazard Capital Upgrades Allergen (AGN) to Buy
May 2, 2013 7:11 AM
Morgan Stanley Downgrades Allergen (AGN) to Equalweight
May 1, 2013 2:31 PM
Reduced Competition Adds $35 to Regeneron (REGN) DCF, Deutsche Bank Raises PT to $310
May 1, 2013 12:55 PM
Allergan (AGN) Strong With or Without DARPin - RBC
May 1, 2013 12:02 PM